Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...

The first reveal of clinical data with Eli Lilly’s injectable triple receptor agonist for obesity suggests that the company could have a big winner on its hands if the drug makes it through to ...